Patent · US Active

Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof

US10907139B2 · kind B2 · utility

1Cited by
0References
8Claims
0Family size

Inventors

Key dates

Filing dateOct 2, 2017
Grant dateFeb 2, 2021
Priority date
Expiry dateOct 2, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/08017
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure provides a modified UDP-GlcNAc:Lysosomal Enzyme GlcNAc-1-phosphotransferase with enhanced ability to phosphorylate lysosomal enzymes and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.